Medicare Enrolled

Dr. Andrew Lerman, M.D.

Neurology · Miami, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
3683 S MIAMI AVE STE 420, Miami, FL 33133
7866558010
In practice since 2010 (15 years)
NPI: 1407173974 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lerman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lerman? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Lerman

Dr. Andrew Lerman is a neurology in Miami, FL, with 15 years in practice. Based on federal Medicare data, Dr. Lerman performed 10,975 Medicare services across 1,043 unique beneficiaries.

Between the years covered by Open Payments, Dr. Lerman received a total of $220,298 from 72 pharmaceutical and/or device companies across 1458 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Lerman is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 15 years in practice▲ Top 10% volume in FL$ $220,298 industry payments

Medicare Practice Summary

Medicare Utilization ↗
10,975
Medicare services
Top 10% in FL for neurology
1,043
Unique beneficiaries
$27
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~732 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Botox injection, per unit9,351$5$24
Office visit, established patient, complex (40-54 min)958$144$788
New patient office visit, complex (60-74 min)155$177$976
Needle measurement of electrical activity in arm or leg muscles, limited study96$51$280
Assessment of and care planning for patient with impaired thought processing, typically 60 minutes92$227$1,021
EEG, extended monitoring85$366$1,914
Office visit, established patient (30-39 min)82$97$562
Nerve conduction, 9-10 studies55$176$960
New patient office visit (45-59 min)38$136$730
Annual depression screening28$19$77
Nerve conduction, 11-12 studies22$207$1,116
Measurement of brain wave activity (eeg), awake and drowsy13$304$1,599
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$220,298
Total received (2018-2024)
Avg $31,471/year across 7 years
Top 3% in FL for neurology
72
Companies
1,458
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$192,784 (87.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$21,727 (9.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$5,788 (2.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$64,854
2023
$68,910
2022
$28,695
2021
$13,188
2020
$5,741
2019
$16,222
2018
$22,689

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Neurocrine Biosciences, Inc.
$78,641
Amneal Pharmaceuticals LLC
$23,791
ARGENX US, INC.
$22,456
Neurelis, Inc.
$17,598
ABBVIE INC.
$14,358
Sunovion Pharmaceuticals Inc.
$14,081
UCB, Inc.
$7,078
Supernus Pharmaceuticals, Inc.
$6,685
Neurocrine BioSciences, Inc.
$5,600
SCILEX PHARMACEUTICALS INC.
$3,987
MDD US Operations, LLC
$3,814
EISAI INC.
$2,677
Eisai Inc.
$2,600
Abbott Laboratories
$2,302
UPSHER-SMITH LABORATORIES LLC
$994
Novartis Pharmaceuticals Corporation
$932
Allergan, Inc.
$854
SK Life Science, Inc.
$786
Teva Pharmaceuticals USA, Inc.
$783
JAZZ PHARMACEUTICALS INC.
$762
Biohaven Pharmaceuticals, Inc.
$693
PFIZER INC.
$666
Adamas Pharmaceuticals, Inc.
$624
Biogen, Inc.
$601
Greenwich Biosciences, Inc.
$596
Acorda Therapeutics, Inc
$560
Allergan Inc.
$549
Lilly USA, LLC
$542
Lundbeck LLC
$344
Biohaven Pharmaceutical Holding Company Ltd.
$324
Kyowa Kirin, Inc.
$309
Takeda Pharmaceuticals U.S.A., Inc.
$268
Amgen Inc.
$267
Upsher-Smith Laboratories LLC
$256
GENZYME CORPORATION
$193
IMPEL PHARMACEUTICALS INC.
$189
Alexion Pharmaceuticals, Inc.
$168
Avion Pharmaceuticals
$168
CSL Behring
$156
LivaNova USA, Inc.
$154
Scilex Pharmaceuticals Inc.
$142
ACADIA Pharmaceuticals Inc
$141
AbbVie Inc.
$120
Impax Laboratories, Inc.
$115
Sumitomo Pharma America, Inc.
$106
Avanir Pharmaceuticals, Inc.
$96
Alfasigma USA, Inc.
$89
Harmony Biosciences LLC
$89
Octapharma USA, Inc.
$79
GE HEALTHCARE
$78
AQUESTIVE THERAPEUTICS, INC.
$77
Otsuka America Pharmaceutical, Inc.
$70
GRT US Holding, Inc.
$65
BANNER LIFE SCIENCES, LLC
$64
MITSUBISHI TANABE PHARMA AMERICA, INC.
$62
Alnylam Pharmaceuticals Inc.
$52
Boston Scientific Corporation
$46
AstraZeneca Pharmaceuticals LP
$41
Life Molecular Imaging Ltd
$40
Merz Pharmaceuticals, LLC
$38
Grifols USA, LLC
$37
Promius Pharma LLC
$34
Vertical Pharmaceuticals, LLC
$34
Almatica Pharma LLC
$30
Corium, LLC
$24
Celgene Corporation
$24
Medtronic, Inc.
$20
Averitas Pharma Inc.
$20
Aprecia Pharmaceuticals, LLC
$19
Janssen Pharmaceuticals, Inc
$19
Strongbridge US INC.
$14
Electronic Waveform Lab, Inc.
$13
Top 3 companies account for 56.7% of total payments
Associated products mentioned in payments ›
ACTIVA PC · ADD-VANTAGE · ADUHELM · AFINITOR · AIMOVIG · AJOVY · AMYVID · APTIOM · AUBAGIO · AUSTEDO · Adlarity · Aimovig · Apokyn · Austedo XR · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · BRILINTA · Briviact · COMIRNATY · COPAXONE · Cenobamate · DUOPA · Dhivy · ELIQUIS · ELYXYB - CELECOXIB · EMGALITY · EPIDIOLEX · Epidiolex · Fintepla · Fycompa · GOCOVRI · Gamunex-C · Gocovri · HYQVIA · Hizentra · INBRIJA · INFINITY · INGREZZA · KESIMPTA · KEVEYIS · KISUNLA · KYNMOBI · LORZONE · LYRICA · Leqembi · MAYZENT · NAMZARIC · NAPRELAN · NEURACEQ · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nourianz · Nuedexta · ONGENTYS · ONGENTYS 50MG CAPSULES 30 · ONPATTRO · OSMOLEX ER · OXTELLAR XR · Ongentys · PANZYGA · PAXLOVID · PLEGRIDY · Ponvory · QULIPTA · QUTENZA · Qutenza · RADICAVA · REXULTI · REYVOW · RYTARY · Rystiggo · SOLIRIS · SYMPAZAN · Spritam · TOPIRAMATE Extended Release Capsules · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · VALTOCO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VRAYLAR · VUMERITY · VYALEV · VYEPTI · VYVGART · VYVGART HYTRULO · Vercise · Vimpat · WAINUA · WAKIX · Xeomin · ZEMBRACE SYMTOUCH · ZEMBRACE SYMTOUCH SUMATRIPTAN INJECTION · ZEPOSIA · ZTLido · Zembrace SymTouch Sumatriptan Injection · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (88%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for neurology in FL.

Equivalent to $2,007 per 100 Medicare services performed
Looking for a neurology in Miami?
Compare neurologys in the Miami area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Geographic Context

Neurologys within 10 mi
269
Per 100K population
10.0
County median income
$68,694
Nearest hospital
DOCTORS HOSPITAL
2.5 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Lerman is a mixed practice specialist, with above-average Medicare volume (top 10% in FL), and high industry engagement (speaking/promotional, top 3%), with 15 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Lerman experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Lerman performed 9,351 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lerman receive payments from pharmaceutical companies?
Yes. Dr. Lerman received a total of $220,298 from 72 companies across 1,458 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lerman's costs compare to other neurologys in Miami?
Dr. Lerman's average Medicare payment per service is $27. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lerman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →